AtriCure Total Liabilities 2010-2025 | ATRC
AtriCure total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
| AtriCure Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $148 |
| 2023 | $148 |
| 2022 | $129 |
| 2021 | $132 |
| 2020 | $302 |
| 2019 | $311 |
| 2018 | $107 |
| 2017 | $107 |
| 2016 | $108 |
| 2015 | $86 |
| 2014 | $26 |
| 2013 | $39 |
| 2012 | $20 |
| 2011 | $18 |
| 2010 | $17 |
| 2009 | $18 |
| AtriCure Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-06-30 | $144 |
| 2025-03-31 | $137 |
| 2024-12-31 | $148 |
| 2024-09-30 | $150 |
| 2024-06-30 | $135 |
| 2024-03-31 | $135 |
| 2023-12-31 | $148 |
| 2023-09-30 | $137 |
| 2023-06-30 | $132 |
| 2023-03-31 | $128 |
| 2022-12-31 | $129 |
| 2022-09-30 | $132 |
| 2022-06-30 | $131 |
| 2022-03-31 | $122 |
| 2021-12-31 | $132 |
| 2021-09-30 | $125 |
| 2021-06-30 | $316 |
| 2021-03-31 | $309 |
| 2020-12-31 | $302 |
| 2020-09-30 | $290 |
| 2020-06-30 | $287 |
| 2020-03-31 | $300 |
| 2019-12-31 | $311 |
| 2019-09-30 | $303 |
| 2019-06-30 | $102 |
| 2019-03-31 | $99 |
| 2018-12-31 | $107 |
| 2018-09-30 | $108 |
| 2018-06-30 | $111 |
| 2018-03-31 | $117 |
| 2017-12-31 | $107 |
| 2017-09-30 | $110 |
| 2017-06-30 | $107 |
| 2017-03-31 | $106 |
| 2016-12-31 | $108 |
| 2016-09-30 | $106 |
| 2016-06-30 | $105 |
| 2016-03-31 | $81 |
| 2015-12-31 | $86 |
| 2015-09-30 | $40 |
| 2015-06-30 | $31 |
| 2015-03-31 | $25 |
| 2014-12-31 | $26 |
| 2014-09-30 | $22 |
| 2014-06-30 | $22 |
| 2014-03-31 | $24 |
| 2013-12-31 | $39 |
| 2013-09-30 | $21 |
| 2013-06-30 | $19 |
| 2013-03-31 | $20 |
| 2012-12-31 | $20 |
| 2012-09-30 | $20 |
| 2012-06-30 | $21 |
| 2012-03-31 | $22 |
| 2011-12-31 | $18 |
| 2011-09-30 | $18 |
| 2011-06-30 | $19 |
| 2011-03-31 | $21 |
| 2010-12-31 | $17 |
| 2010-09-30 | $20 |
| 2010-06-30 | $19 |
| 2010-03-31 | $17 |
| 2009-12-31 | $18 |
| 2009-09-30 | $18 |
| 2009-06-30 | $13 |
| 2009-03-31 | $6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.764B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.627B | 26.81 |
| Boston Scientific (BSX) | United States | $152.250B | 36.31 |
| Stryker (SYK) | United States | $144.004B | 29.31 |
| EssilorLuxottica (ESLOY) | France | $135.646B | 0.00 |
| Medtronic (MDT) | Ireland | $118.875B | 16.86 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.688B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.538B | 24.28 |
| ResMed (RMD) | United States | $41.629B | 29.77 |
| GE HealthCare Technologies (GEHC) | United States | $33.329B | 15.66 |
| Agilent Technologies (A) | United States | $32.420B | 21.14 |
| Terumo (TRUMY) | Japan | $27.464B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $25.691B | 16.99 |
| Insulet (PODD) | United States | $21.458B | 71.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.814B | 12.61 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.750B | 0.00 |
| Baxter (BAX) | United States | $12.050B | 9.31 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.159B | 26.30 |
| Lantheus Holdings (LNTH) | United States | $3.812B | 10.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.350B | 23.44 |
| Prestige Consumer Healthcare (PBH) | United States | $3.144B | 13.95 |
| Perrigo (PRGO) | Ireland | $3.030B | 7.57 |
| ICU Medical (ICUI) | United States | $2.669B | 18.17 |
| Haemonetics (HAE) | United States | $2.528B | 11.28 |
| LeMaitre Vascular (LMAT) | United States | $2.097B | 44.96 |
| Curaleaf Holdings (CURLF) | Canada | $1.850B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.800B | 77.27 |
| QuidelOrtho (QDEL) | United States | $1.605B | 10.10 |
| AdaptHealth (AHCO) | United States | $1.259B | 17.94 |
| Phibro Animal Health (PAHC) | United States | $1.157B | 14.79 |
| Acuren (TIC) | United States | $1.119B | 0.00 |
| Neogen (NEOG) | United States | $1.110B | 17.62 |
| BioLife Solutions (BLFS) | United States | $1.072B | 2237.00 |
| Tilray Brands (TLRY) | Canada | $1.012B | 0.00 |
| InMode (INMD) | Israel | $0.872B | 8.07 |
| Kestra Medical Technologies (KMTS) | United States | $0.752B | 0.00 |
| Valneva SE (VALN) | France | $0.723B | 0.00 |
| Surmodics (SRDX) | United States | $0.543B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.47 |
| SNDL (SNDL) | Canada | $0.528B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| CeriBell (CBLL) | United States | $0.444B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.405B | 13.96 |
| Evolus (EOLS) | United States | $0.373B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.366B | 0.00 |
| Owens & Minor (OMI) | United States | $0.358B | 3.17 |
| Capricor Therapeutics (CAPR) | United States | $0.357B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.324B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.283B | 21.44 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.251B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.239B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.230B | 0.00 |
| Brainsway (BWAY) | Israel | $0.229B | 60.50 |
| Organigram Global (OGI) | Canada | $0.220B | 0.00 |
| Quanterix (QTRX) | United States | $0.213B | 0.00 |
| Exagen (XGN) | United States | $0.206B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.04 |
| Jushi Holdings (JUSHF) | United States | $0.157B | 0.00 |
| Biote (BTMD) | United States | $0.154B | 4.62 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.07 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.16 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.084B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Nephros (NEPH) | United States | $0.048B | 37.42 |
| Zynex (ZYXI) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.02 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |